Recent Headlines
Within Pharmaceuticals
The Rare Cancer That Can Return Decades Later Brings Patients Together to Launch the Solitary Fibrous Tumor Foundation
The Solitary Fibrous Tumor Foundation (SFTF) today announced its launch as the first patient- and supporter-led nonprofit organization dedicated entirely to Solitary Fibrous Tumor (SFT), an ultra-rare sarcoma.The announcement comes during Sarcoma Awareness Month, observed globally each July. SFT... - September 17, 2026 - Solitary Fibrous Tumor Foundation
Microvascular Therapeutics Appoints Charles Garrison, MD, to Scientific Advisory Board
Dr Charles Garrison, an experienced pathologist, biotechnology entrepreneur, and life sciences investor will advise MVT on scientific and medical development as new Scientific Advisory Board member. - September 14, 2026 - Microvascular Therapeutics, Inc.
MVT Nanobubbles Enable Non-Thermal Focused Ultrasound Ablation in Preclinical Brain Tumor Study
University of Utah researchers use MVT-101 phase-shift nanobubbles with focused ultrasound and MRI to confirm treatment location - September 14, 2026 - Microvascular Therapeutics, Inc.
Tristela Capital Partners Announces New Platform Acquisition of Louisiana-Based Pediatric Rural Healthcare Group
Tristela Capital Partners has acquired Pediatric Group of Acadiana and its affiliated management services organization, Independent Physician Services, creating a new healthcare platform focused on expanding pediatric care access and supporting growth across underserved communities in South Central Louisiana. - September 08, 2026 - Tristela Capital Partners
Kepon Biotech Addresses Global Biopharma Supply‑Chain Pain Points with China‑Based One‑Stop Procurement System
Kepon Biotech is a Chinese one‑stop supply‑chain partner for life‑science clients. It resolves procurement challenges: scattered suppliers, complex cross‑border compliance, variable batch quality and long lead‑times. It provides consolidated sourcing, special‑goods compliance, graded cold‑chain logistics and global certifications for cell lines, culture media, LAL reagents and clinical materials, delivering streamlined, low‑risk procurement for pharma, IVD, CRO/CDMO and research institutes. - September 07, 2026 - Shanghai Kepon Biotech Co., Ltd.
Asclepii Selected to Exhibit Poseidon at Vizient Innovative Technology Exchange
Asclepii will showcase its FDA 510(k)-cleared Poseidon™ Nanosilver Hydrogel at Vizient’s Innovative Technology Exchange in Las Vegas on September 24, marking an important milestone in the company’s commercial expansion and bringing its wound care technology to healthcare leaders across Vizient’s network. - September 04, 2026 - Asclepii
Helix BioMedix Completes $2 Million Private Placement to Advance Xeroderma Pigmentosum Development Program
Financing strengthens balance sheet and accelerates advancement of proprietary DNA repair technology targeting UV-induced DNA damage. - August 29, 2026 - Helix BioMedix, Inc
VMRD Launches Rapid Horse-Side Insulin Test to Decrease Risk of Laminitis in Metabolic Horses
VMRD, Inc. is thrilled to share the launch of their exciting new test for horse-side measurement of insulin in horses. Run on the same palm-sized reader as VMRD SAA and Foal IgG, this highly portable multi-functional testing platform embodies VMRD’s vision of improving animal health through... - August 28, 2026 - VMRD, Inc.
McObject Announces eXtremeDB 9.0 Featuring Native ANN Indexes and a New Ultra Lightweight Edge Client for IoT
McObject announces eXtremeDB 9.0, a major update to its embedded database system introducing two significant advancements for developers building intelligent, resource constrained systems: native Approximate Nearest Neighbor (ANN) indexes and a new Edge Client requiring as little as 8 KB of... - August 27, 2026 - McObject
The Peptide App Opens Public COA Evidence Index with 5,225 Documents
The Peptide App launched a free public COA Evidence Index containing 5,225 documents, along with a label-first reconstitution calculator. The launch addresses a fast-changing online peptide market: 60 of 82 storefront domains with available registration dates in the app’s current vendor sample were registered in 2024 or later. The index helps people inspect testing records, sources, and limitations without treating a COA as proof of product quality or safety. - August 26, 2026 - The Peptide App
Luminex Wellness & Aesthetics Expands Concierge Perimenopause & Menopause Care with Personalized Hormone Evaluations - Initial Consultation May be Covered by Insurance
New approach focuses on treating women—not just lab results—while helping address common symptoms of perimenopause and menopause. - August 24, 2026 - Luminex Wellness & Aesthetics
Kepon Biotech Launches Integrated Cross‑Border Risk‑Control Solutions for Global Cell Culture Media Trade
Kepon Biotech handles import‑export for fermentation, research and GMP clinical‑grade cell culture media. It addresses cross‑border risks such as bioactivity degradation, complex global regulations and customs detention. With EAC, REACH, FDA, TGA, PMDA, CMDCAS and Halal credentials, it delivers grade classification, global certification, light‑shielded cold‑chain logistics and multilingual customs documents for global CDMOs, biomanufacturers and research labs. - August 19, 2026 - Shanghai Kepon Biotech Co., Ltd.
Kepon Biotech Launches Integrated Cross‑Border Solutions for Global Spermidine Procurement
Kepon Biotech provides multi‑grade spermidine and spermidine trihydrochloride for food, pharma, cosmetics and life‑science research. It mitigates cross‑border risks such as oxidative degradation, complex certification rules and HS misclassification. Backed by EAC, REACH, FDA and Halal credentials, it delivers one‑stop certification, nitrogen‑sealed temperature‑controlled logistics and multilingual customs documents for manufacturers, labs and distributors across EAEU, EU, U.S. and Middle‑East. - August 19, 2026 - Shanghai Kepon Biotech Co., Ltd.
Kepon Biotech Launches One-Stop Cross-Border Compliance & Logistics Solutions for Life Science Reagents
Kepon Biotech provides a one-stop global compliance and supply system for life science procurement. It solves core cross-border challenges including complex customs clearance, unstable cold-chain logistics, fragmented regional regulations. The company offers standardized biochemical reagents, reference standards and cell culture media, with full compliance support and segmented temperature-controlled logistics, delivering reliable, low-risk sourcing for global labs and pharmaceutical manufacture - August 19, 2026 - Shanghai Kepon Biotech Co., Ltd.
Kepon Biotech Launches Integrated Cross‑Border Export Solutions for Global LAL Endotoxin‑Testing Reagent Procurement
Kepon Biotech delivers factory‑sourced LAL endotoxin‑testing kits for biopharma, vaccine and medical‑device clients. Working with ISO13485‑certified manufacturers, it provides regional compliance paperwork, 2‑8°C cold‑chain logistics and low‑MOQ trial orders across CIS, Southeast Asia, Middle East, EU and North America. Its one‑stop export solution fixes customs detention, reagent deactivation and raw‑material stock‑out risks for 1000+ users in 50+ countries. - August 18, 2026 - Shanghai Kepon Biotech Co., Ltd.
Kepon Biotech Unveils Full-Link Risk Control & Compliance Solutions for Global Cell Culture Media Trade
Global labs and biopharma firms encounter common cell culture media procurement risks: inconsistent batches, customs delays, cold chain product inactivation and inflexible high MOQs. Shanghai Kepon Biotech releases a full cross-border supply solution and procurement risk guide, offering flexible samples, one-stop biological goods clearance and segmented cryogenic logistics for global cell research, biotech and diagnostic manufacturers. - August 18, 2026 - Shanghai Kepon Biotech Co., Ltd.
Kepon Biotech Launches Comprehensive Cross-Border Procurement & Risk Control Solutions for Industrial Fine Chemicals
Global factories, energy plants and research labs run into widespread procurement risks for industrial chemicals: inconsistent purity, hazardous goods customs blockages, failed long-distance shipping, rigid high MOQs and incomplete compliance documents. Shanghai Kepon Biotech releases an integrated cross-border supply system and complete pitfall guide, providing flexible trial orders, one-stop chemical customs agency and dedicated hazardous cold chain logistics for biotech, pharmaceutical. - August 17, 2026 - Shanghai Kepon Biotech Co., Ltd.
Kepon Biotech Launches Integrated Cross-Border Procurement and Risk Control Solutions for High-Purity Organic & Inorganic Chemicals
Global labs and pharma face organic & inorganic chemical procurement risks including unstable purity, customs detention, failed shipping, high MOQs and incomplete SDS docs. Shanghai Kepon Biotech releases a cross-border supply & risk guide with flexible samples, full chemical clearance and custom cold chain logistics for life science and new energy industries. - August 17, 2026 - Shanghai Kepon Biotech Co., Ltd.
Shanghai Kepon Biotech Launches Full Risk-Control Cross-Border Solutions for Certified Reference Standards Procurement
Global labs, pharma and food testers face China reference standards cross-border risks: poor batch traceability, customs delays, rigid MOQs, cold chain breakdowns and missing COA/SDS. Shanghai Kepon Biotech offers integrated supply, special goods clearance and segmented cold chain for life science, new energy and food testing industries. - August 17, 2026 - Shanghai Kepon Biotech Co., Ltd.
Food Safety Standards Raw Material Procurement Solutions & Risk Avoidance Guide Released by Shanghai Kepon Biotech for Global Food Testing & Food Manufacturing Plants
Global food manufacturers and third-party food testing labs face severe procurement risks for food safety reference standards: inconsistent batch purity, cross-border food regulatory document gaps, strict customs inspection, high MOQ limits and incomplete compliance certification. Shanghai Kepon Biotech launches integrated cross-border supply system, one-stop food safety filing and traceable certified standards for food testing, beverage and food processing industries worldwide. - August 16, 2026 - Shanghai Kepon Biotech Co., Ltd.
Geoprise Announces First-Ever OpenAPI Bridge to Fully Connect ERP and Agentic AI
According to Openapi, Europe’s biggest API Marketplace, no commercial ERP applications expose all their screens, internal functions, and reports as OpenAPI-conforming APIs out of the box. With today’s announcement, GM-X Auto becomes the first and only ERP application in the world to expose all of its 3,871 functions, screens, and reports to Model Context Protocol servers through 456 published APIs compatible with the OpenAPI Specification (OAS). - August 13, 2026 - Geoprise Technologies Corporation
New 2026 Report Reveals an AI/LLM Gap Between Biopharma Sponsors and Their CROs/Vendors
Life Science Strategy Group looks beyond frontier-AI hype to show how biopharma teams use AI and LLMs in daily work, and where their CRO and vendor partners are falling short. 71% of sponsors rate their own AI/LLM output highly. Only 27% say the same of their CROs and vendors. - August 12, 2026 - Life Science Strategy Group, LLC
DNA Harvest Partners and ToolGen Announce Strategic Partnership to Accelerate AI-Guided Predictive Breeding for Gene-Edited Crops
DNA Harvest Partners Pte. Ltd. (DNAHP), one of the world's most advanced AI-guided predictive breeding companies, and ToolGen, a global leader in CRISPR-Cas9 gene editing technology, today announced a strategic partnership to accelerate the development of superior rapeseed (Brassica napus)... - August 11, 2026 - DNA Harvest Partners Pte. Ltd.
Ferrari and Dr. David Pincus of Pincus Plastic Surgery Unveil a Luxury Lounge Experience at the Hamptons Concours
The roar of rare Ferraris, the unmistakable elegance of the Hamptons, and one of plastic surgery's most recognizable luxury brands came together for an unforgettable weekend at the 2026 Hamptons Concours, produced by luxury event visionary Bradford Rand. Widely regarded as one of the East Coast's... - August 10, 2026 - Pincus Plastic Surgery
ecotera health Submits Decentralized Urine Microplastics / Nanoplastics Observational Study for IRB Review
Study will evaluate an at-home approach to longitudinal microplastics / nanoplastics monitoring in urine using the EcoExposure™ platform - August 08, 2026 - ecotera health
Plastic Surgeon Dr. David Pincus Sponsors the Hamptons Concours d’Elegance Supporting the Southampton Animal Shelter Foundation
Plastic Surgeon Dr. David Pincus and Pincus Plastic Surgery proudly sponsored the 2026 Hamptons Concours d'Elegance, one of the Hamptons' premier luxury charity events, bringing together exotic automobiles, luxury brands, community leaders, and philanthropists for a day dedicated to supporting the... - August 06, 2026 - Pincus Plastic Surgery
Minus K Technology Launches It Educational Giveaway for Universities and Colleges in the USA
Minus K Technology announces its 11th Educational Giveaway of passive mechanical vibration isolators for Universities and Colleges within the USA. Winners get a free brand new negative-stiffness vibration isolator to be used at their school. - August 03, 2026 - Minus K Technology Inc.
Microvascular Therapeutics Highlights the Future of Ultrasound Theranostics in Comprehensive Wiley Review
Microvascular Therapeutics, Inc. (MVT) today announced publication of a comprehensive review in Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology (WIREs Nanomedicine and Nanobiotechnology), a leading peer-reviewed journal with a 2025 Journal Impact Factor of 8.6, entitled,... - July 28, 2026 - Microvascular Therapeutics, Inc.
Toledo Takes on ALS Returns July 31, Expected to Surpass $1 Million Raised for ALS Research
Fourth annual community fundraiser brings local breweries, businesses and supporters together at Fifth Third Field to accelerate the search for ALS treatments. - July 23, 2026 - ALS Therapy Development Institute
Pacto Medical Wins Red Dot Design Concept Award 2026 for Slimshot® Compact Prefilled Syringe
Slimshot® recognized in Medical Devices & Technology Concept category; product selected for display at Red Dot Design Museum in Singapore. - July 14, 2026 - Pacto Medical
Validation Management Solutions Expands Leadership Team with the Appointment of Remoun Amin as Partner
Validation Management Solutions (VMS) has appointed Remoun Amin as Partner, marking an important milestone in the company's growth. With more than two decades of life sciences experience, Amin strengthens VMS's ability to deliver expert CQV, calibration, and temperature mapping services while advancing its vision to help clients build assurance that scales with them. - July 09, 2026 - Validation Managment Solutions
Hemanext Expands Commercial Footprint Through Strategic Partnership with OneBlood
Hemanext Inc. announced a strategic production partnership with OneBlood, one of the nation's largest independent blood centers, marking a significant milestone in Hemanext's commercial expansion and accelerating adoption of Hemanext ONE® across the United States. - July 06, 2026 - Hemanext
ACTIIV REMEDY Named “Best Dandruff Shampoo” in the 2026 SHAPE Skin Awards
ACTIIV, the professional hair wellness brand known for combining advanced scalp science with clean, plant-powered formulations, today announced that its REMEDY Dandruff Shampoo has been named Best Dandruff Shampoo in the 2026 SHAPE Skin Awards. - July 03, 2026 - ACTIIV
Emotion AI Thinks There's One Right Answer. A High School Researcher is Proving There Isn't.
A non-commercial research project led by high school student Evelyn Kim at Singapore American School has opened public participation. Contributors watch ten short video clips and record how they read each person's emotion — no right or wrong answers, 10 to 15 minutes. The study challenges a foundational assumption of emotion-recognition AI: that everyone reads a face the same way. Anyone 14 or older can participate. - July 03, 2026 - MindLensLab
Microvascular Therapeutics to Present Late-Breaking Clinical Data on CardiSon™ (MVT-100) at the 2026 American Society of Echocardiography Meeting.
Clinical Study Demonstrates Superior Left Ventricular Opacification and Significantly Reduced Acoustic Shadowing Compared with Definity®. - June 26, 2026 - Microvascular Therapeutics, Inc.
Cancer Survivor Expands Scottsdale Wellness Center with Advanced Recovery Therapies
A Scottsdale-based wellness center is expanding its offerings with a combination of advanced, non-invasive therapies designed to support individuals navigating cancer, Lyme disease, neurological conditions, and chronic pain. The Shift Healing and Wellness in North Scottsdale is bringing together technologies rarely found in one place - including a motorized rehabilitation system (the Quadriciser), oxygen therapy, and red light therapy - with a personalized, whole-body approach to care. - June 25, 2026 - The Shift Healing and Wellness
OurJrney Expands Beyond Online Sales and Seeks Retail Distribution Partners Across the United States
Following strong consumer response and growing brand momentum, OurJrney is expanding beyond e-commerce and opening opportunities for retail distributors and influencer partnerships worldwide. - June 24, 2026 - PureJourney Inc
Hundreds of Cyclists to Ride Across Three States to Advance ALS Research
More than 400 cyclists, volunteers, and supporters will gather in Durham, New Hampshire on June 27–28 for the 24th annual Tri-State Trek, a two-day cycling event benefiting the ALS Therapy Development Institute (ALS TDI), the world's most comprehensive drug discovery institute dedicated... - June 23, 2026 - ALS Therapy Development Institute
Good Mana and Voyaging Foods Announce Strategic Collaboration to Scale Hawai‘i-Grown Functional Foods and Nutraceuticals
Good Mana and Voyaging Foods announced a strategic collaboration to scale Hawai‘i-grown functional foods and nutraceuticals by transforming crops like turmeric, taro, breadfruit, and sweet potato into shelf-stable wellness products. The partnership aims to reduce food waste, support farmers, preserve nutrients, and make healthy local foods more accessible. - June 19, 2026 - Good Mana
10,000 Customers Finally Found a Turmeric That Works — OurJrney Marks Sales Milestone
The nano-particle absorption breakthrough that made piperine obsolete has now reached 10,000 units sold — with customers pointing to both noticeable results and a taste that sets it apart from traditional turmeric supplements. - June 17, 2026 - PureJourney Inc
Wallflower Cannabis House Celebrates Six Years of Serving Las Vegas
Wallflower Cannabis House, one of Las Vegas’s most beloved independent dispensaries, is turning six — and it’s celebrating the way it does everything: by putting its customers first. On Friday, June 19, Wallflower will host a Customer Appreciation Day at both the Blue Diamond and Inspirada locations, offering a full day of exclusive deals, community connection, and the expert-guided cannabis experience that locals have come to count on. - June 16, 2026 - Wallflower Cannabis House
University of Michigan Health System Has Selected TwitchView® as Its Quantitative Train-of-Four (TOF) Monitoring Solution
Blink Anesthesia is proud to announce that the University of Michigan Health System has selected TwitchView® as its quantitative train-of-four (TOF) monitoring solution. The University of Michigan is home to the Multicenter Perioperative Outcomes Group (MPOG), the largest and most... - June 15, 2026 - Blink Anesthesia
OurJrney NeuroMatcha Gives High Performers a Way to Finish The Day as Sharp as They Started
This Daily Cognitive Boost combines premium-grade matcha, Alpha-GPC, and functional mushrooms into a daily cognitive ritual that eliminates the afternoon crash with sustained, calm mental clarity. - June 12, 2026 - PureJourney Inc
While Telehealth Giants Face Federal Scrutiny, Ivia Health Has Been Quietly Getting It Right
Ivia Health, a LegitScript-certified, HIPAA-compliant GLP-1 telehealth platform operating across 40+ U.S. states, is launching Ivia Health Benefits, an employer GLP-1 benefit program built on a certified, compliant foundation. As federal regulators crack down on non-compliant telehealth platforms, Ivia offers employers and patients a transparent, cash-pay alternative built right from day one. - June 11, 2026 - Ivia Health, LLC
Novugen Pharma (USA) LLC Launches ANDA-Approved Everolimus Tablets in the U.S.
Novugen Pharma (USA) LLC has launched Everolimus Tablets 2.5 mg, 5 mg, 7.5 mg, and 10 mg in the U.S. market, following the approval of its Abbreviated New Drug Application (ANDA) by the U.S. Food and Drug Administration (USFDA) in October 2025, further strengthening Novugen’s presence in a... - June 10, 2026 - Novugen
Novus Hi-Tech to Demonstrate AI-Powered ADAS and Fleet Safety Technologies at Commercial Vehicle Forum 2026
Novus Hi-Tech will showcase its AI-powered ADAS, Driver Monitoring Systems (DMS), and fleet safety solutions at Commercial Vehicle Forum 2026 in Pune. As a Tier 1 supplier to commercial vehicle OEMs, the company will demonstrate technologies for collision avoidance, driver fatigue detection, telematics, and fleet intelligence. The solutions support safety compliance, reduce operational risks, and help fleet operators improve efficiency and driver performance. - June 09, 2026 - Novus Hi-Tech
MyConcussionDR Announces Public Support for the American Center for Cures
Brain health education team joins national initiative to fund the prevention and cure of major diseases, citing its shared commitment to families, accountability, and long-term neurological health. - June 08, 2026 - MyconcussionDR
Alera Bio Appoints David McCullough as Chief Executive Officer
Alera Bio announced the appointment of David McCullough as Chief Executive Officer. An experienced biotechnology executive, McCullough will lead corporate strategy, financing, organizational development, and execution of the company’s clinical and regulatory roadmap. He will oversee advancement of AB-101, Alera’s novel therapy for MCT-8 deficiency, as the company works to bring new hope to patients and families affected by this devastating rare neurodevelopmental disorder. - June 04, 2026 - Alera Bio
LongevityPlan.AI Opens Its Wellness Club to the Public with a Free Month-Long Longevity Workshop Series This June
20+ Leading Scientists, Physicians, Coaches, and Fitness Experts Headline 90+ Free Live Sessions on Peptides, Hormones, Recovery, Breathwork, Genomics, and Cycle-Aligned Performance - May 31, 2026 - LongevityPlan.AI
The Als 100 Announces Fourth Annual Event and More Than $1 Million Raised
Two-Day Celebration of Golf, Community, and Purpose Set for June 15–16 in New Canaan and Windsor, CT. The ALS 100, the premier endurance golf fundraiser in the fight against ALS, announced details for its fourth annual event which will now be a two-day experience, taking place June 15–16, 2026, in Connecticut. Additionally, the organization has announced that it has now collectively raised more than $1 million since its founding in 2023. - May 27, 2026 - ALS Therapy Development Institute